Annual report pursuant to Section 13 and 15(d)

Recapitalization - Schedule of Net current assets (Details)

v3.22.4
Recapitalization - Schedule of Net current assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Sep. 16, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash and cash equivalents $ 167,467   $ 92,302 $ 173,984
Marketable securities $ 34,837   $ 38,067  
Tyme Therapeutics, Inc.        
Cash and cash equivalents   $ 14,898    
Marketable securities   52,220    
Prepaid expenses   1,350    
Total   $ 68,468